Skip to main content
logo
Amgen Inc. (AMGN)
NASDAQ: AMGN · Real-Time Price · USD
291.77
-0.32 (-0.11%)
At close: Oct 29, 2025, 4:00 PM EDT
293.00
+1.23 (0.42%)
After-hours: Oct 29, 2025, 7:56 PM EDT

Amgen Revenue by Type

Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 3, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018
Product Sales
33.51B32.78B32.03B31.14B29.54B28.18B26.91B25.63B
Product Sales Growth
13.44%16.32%19.01%21.51%16.68%13.11%8.50%4.52%
Other
1.41B1.34B1.40B1.39B1.39B1.35B1.28B1.20B
Other Growth
0.93%-0.44%9.14%15.45%10.21%5.97%-15.90%-33.48%

Product Sales by Geography

Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 3, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018
United States
24.47B23.99B23.30B22.66B21.37B20.27B19.27B18.20B
United States Growth
14.50%18.35%20.91%24.54%18.94%14.64%8.62%4.57%
Rest of World
9.04B8.79B8.73B8.48B8.17B7.91B7.64B7.43B
Rest of World Growth
10.67%11.11%14.23%14.10%11.15%9.36%8.22%4.40%

Operating Expense Breakdown

Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 3, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018
Selling, General, and Administrative
6.88B6.98B7.10B7.49B7.22B6.73B6.18B5.48B
Selling, General, and Administrative Growth
-4.70%3.66%14.84%36.79%33.43%23.60%14.13%3.99%
Research and Development
6.40B6.11B5.96B5.77B5.40B5.07B4.78B4.57B
Research and Development Growth
18.53%20.48%24.67%26.24%17.28%11.82%7.89%2.60%
Other Expenses
1.04B973.00M248.00M192.00M765.00M836.00M879.00M840.00M
Other Expenses Growth
35.82%16.39%-71.79%-77.14%280.60%26.48%74.75%42.86%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.